Strategic Financial Concepts LLC Invests $1.33 Million in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Strategic Financial Concepts LLC purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the fourth quarter, Holdings Channel reports. The firm purchased 16,963 shares of the company’s stock, valued at approximately $1,326,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Argus Investors Counsel Inc. purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $224,000. Bleakley Financial Group LLC lifted its stake in GE HealthCare Technologies by 3.8% in the fourth quarter. Bleakley Financial Group LLC now owns 17,119 shares of the company’s stock worth $1,338,000 after acquiring an additional 624 shares during the period. Choreo LLC grew its holdings in GE HealthCare Technologies by 68.2% during the 4th quarter. Choreo LLC now owns 32,245 shares of the company’s stock worth $2,533,000 after acquiring an additional 13,077 shares in the last quarter. Tectonic Advisors LLC purchased a new position in GE HealthCare Technologies during the 4th quarter valued at about $651,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of GE HealthCare Technologies by 15.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 131,774 shares of the company’s stock valued at $10,466,000 after purchasing an additional 17,354 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the topic of several research reports. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

GE HealthCare Technologies Stock Performance

GEHC opened at $87.50 on Tuesday. The company has a market cap of $39.98 billion, a P/E ratio of 24.04, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm’s 50-day moving average price is $83.43 and its 200-day moving average price is $85.34. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.55.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.